<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR14">
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Ariza-Saenz</surname>
    <given-names>M</given-names>
   </name>
   <name>
    <surname>Espina</surname>
    <given-names>M</given-names>
   </name>
   <name>
    <surname>Calpena</surname>
    <given-names>A</given-names>
   </name>
   <name>
    <surname>Gomara</surname>
    <given-names>MJ</given-names>
   </name>
   <name>
    <surname>Perez-Pomeda</surname>
    <given-names>I</given-names>
   </name>
   <name>
    <surname>Haro</surname>
    <given-names>I</given-names>
   </name>
   <name>
    <surname>Garcia</surname>
    <given-names>ML</given-names>
   </name>
  </person-group>
  <article-title>Design, characterization, and biopharmaceutical behavior of nanoparticles loaded with an HIV-1 fusion inhibitor peptide</article-title>
  <source>Mol Pharm</source>
  <year>2018</year>
  <volume>15</volume>
  <fpage>5005</fpage>
  <lpage>5018</lpage>
  <pub-id pub-id-type="doi">10.1021/acs.molpharmaceut.8b00609</pub-id>
  <?supplied-pmid 30226777?>
  <pub-id pub-id-type="pmid">30226777</pub-id>
 </element-citation>
</ref>
